tiprankstipranks
BioMarin upgraded to Outperform from Perform at Oppenheimer
PremiumThe FlyBioMarin upgraded to Outperform from Perform at Oppenheimer
15d ago
Oppenheimer upgrades BioMarin with stage set for increasing interest
Premium
The Fly
Oppenheimer upgrades BioMarin with stage set for increasing interest
15d ago
Strong Growth Potential and Strategic Initiatives Drive BioMarin Pharmaceutical’s Outperform Rating
Premium
Ratings
Strong Growth Potential and Strategic Initiatives Drive BioMarin Pharmaceutical’s Outperform Rating
16d ago
BioMarin price target raised to $80 from $78 at Scotiabank
PremiumThe FlyBioMarin price target raised to $80 from $78 at Scotiabank
19d ago
BioMarin price target raised to $113 from $109 at UBS
Premium
The Fly
BioMarin price target raised to $113 from $109 at UBS
19d ago
BioMarin Pharmaceutical: Strong Financial Performance and Promising Growth Prospects Warrant Buy Rating
Premium
Ratings
BioMarin Pharmaceutical: Strong Financial Performance and Promising Growth Prospects Warrant Buy Rating
19d ago
BioMarin price target raised to $82 from $81 at Citi
PremiumThe FlyBioMarin price target raised to $82 from $81 at Citi
19d ago
BioMarin Pharmaceutical: Hold Rating Amid Strong Performance and Decelerating Growth Prospects
Premium
Ratings
BioMarin Pharmaceutical: Hold Rating Amid Strong Performance and Decelerating Growth Prospects
19d ago
BioMarin Pharmaceutical’s Strong Financial Performance and Growth Prospects Justify Buy Rating
Premium
Ratings
BioMarin Pharmaceutical’s Strong Financial Performance and Growth Prospects Justify Buy Rating
19d ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100